Breaking News

You are here » Indian-Commodity  :  Corporate  :  Bharti Airtel to deploy MIMO technology in Bengaluru, Kolkata: Report

29-Sep2017

Bharti Airtel to deploy MIMO technology in Bengaluru, Kolkata: Report

Bharti Airtel is reportedly deploying the next gen Massive Multiple-Input Multiple-Output (MIMO) technology in Bengaluru and Kolkata. The deployement of Massive MIMO was India's first 5G capable technology. The company was starting with the first round of deployment in Bangalore and Kolkata; and would expand to other parts of the country soon.

Deployed as part of Airtel's ongoing network transformation program, Project Leap, the Massive MIMO technology will expand existing network capacity by five to seven times using the existing spectrum, thereby improving spectral efficiency.

Customers will now be able to experience two to three times superfast speeds on the existing 4G network. Data speeds will now also be seamless, offering enhanced user experience even indoors, in crowded places and high rise buildings. It would enable multiple users and multiple devices to work simultaneously without facing any congestion or experience issues especially at hotspot locations.

Bharti Airtel is a leading integrated telecommunications company with operations in 18 countries across Asia and Africa.



Related News

View all news

NCLT levies penalty on Tata Chemicals

The National Company Law Tribunal (NCLT) Mumbai, has levied a penalty of Rs 10 lakh on Tata Chemicals for filing a petition fraudulently and with malicious intent to liquidate Raj Process Equipment and......

Reliance Industries' arms to launch new e-commerce platform

Reliance Industries' group companies--Reliance Jio and Retail will launch a new e-commerce platform in the country. This project will empower 12 lakh small retailers in Gujarat.Reliance Industries is India's......

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......